OncoSec Medical Inc (ONCSQ)

[guti]

Let's get a straight evaluation for the risk, since the one trick pony that you are referring to can be utilize in many ways if successful. Once the clinical trial is completed, the share price would eventually drop below a dollar if combination with Keytruda fails. But if results are positive, it will likely rise well above $12, and at the present $4 share price for Oncosec the risk would be of -75% vs. 200% in favor of the upside.

If $2 is your evaluation of a bargain for Oncosec, that would place the company at a 500% increase in the upside once results are released and are positive, even though they would still be without a product in the market. That's a pretty good deal if reachable, since the downside risk for negative results would only be at a 50% loss. That is not considered a bargain but a steal.